Skip to main content

Aquestive Therapeutics, Inc.

AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001398733

In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.

Members of Congress who traded AQST

No member of Congress has reported a trade in Aquestive Therapeutics, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.